The role of omalizumab in idiopathic mast cell activation syndrome.

hörmet iğde m., EYİCE D., TOPRAK İ. D., DEMİR S., ÜNAL D., AKKOR A.

European Academy of Allergy and Clinical Immunology Hybrid Congress, 31 May-3 June 2024, Valencia, İspanya, 31 May 2024, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Istanbul University Affiliated: Yes